One of the controversies of routinemammographyscreening of healthy women is that it detects minimal-riskbreast cancer, including the vast majority of ductal carcinoma in situ (DCIS), which has led to concerns of over-diagnosis and over-treatment. This in turn has led to proposals that DCIS coul...